Harantech
Harantech provides AirLiwell technology that enhances biological therapies and accelerates preclinical research for pharmaceutical development. The company applies its proprietary AirLiwell platform to improve cell culture conditions, biological assays, and therapeutic performance in laboratory settings. Harantech operates as a B2B life‑sciences technology provider serving preclinical researchers, biotech companies, and pharmaceutical developers. The offering targets improved experimental throughput and translational relevance in drug discovery and preclinical workflows.
Harantech
Harantech provides AirLiwell technology that enhances biological therapies and accelerates preclinical research for pharmaceutical development. The company applies its proprietary AirLiwell platform to improve cell culture conditions, biological assays, and therapeutic performance in laboratory settings. Harantech operates as a B2B life‑sciences technology provider serving preclinical researchers, biotech companies, and pharmaceutical developers. The offering targets improved experimental throughput and translational relevance in drug discovery and preclinical workflows.